Friday, June 7, 2019

The Crucible by Arthur Miller Essay Example for Free

The Crucible by Arthur Miller EssayIn the opening scene of The Crucible, the playwright reveals insight into fanny and Elizabeths troubled marriage through Elizabeths subtle passive-aggressive gestures, posteriors incoherent ramblings, and his emotional explosion at the end showing his frustration.Tension between the two immediately increases when prank Proctor comes home late. Apparently, Elizabeth knows about Johns extramarital affair with Abigail. Elizabeths annoyance is find outn when Proctor states, Oh, is it a rabbit In Jonathans trap? Elizabeth replies sarcastic bothy, No, she walked into the house this afternoon I found her sittin in the box seat like she come to visit. When John gets up and kisses Elizabeth, she rejects him further by sampling receiving his gesture. Disappointed and somewhat aware of his wifes unspoken displeasure, he sits down. The mood has become awkward. John makes small talk, stating, Its winter in here yet. On Sunday let you come with me, and we ll walk the farm together I never see such a load of flowers on the earth. Lilacs have a purple smell. Lilac is the smell of nightfall, I think. Massachusetts is a beauty in the alternate The winter remark refers to the cold atmosphere of the two spouses they are talking together but are not communicating anything worthwhile. His unfocused rambling does not successfully establish common ground between the two.He turns to her and watches her. A sense of their separation rises, states the stage directions. Proctor asks, I think youre sad again. are you? Elizabeth, reluctant to cause an argument, replies, You come so late I thought youd gone to Salem this afternoon. However, her attempts are futile because Proctor is set off by Elizabeths blunt remark, Mary Warrens there at Salem today. He screams, Whyd you let her? Your heard me forbid her to go to Salem any moreInsight into their troubled marriage continues when Elizabeth loses all faith in him when Proctor replies For a moment alo ne I was alone with her, aye and Elizabeth replies, Why, then, it is not as you told me. Proctor becomes violent again, warning Elizabeth not to judge him anymore. diddle CitedMiller, Arthur. The Crucible. New York Penguin, 1952.

Thursday, June 6, 2019

Health Care Marketing Essay Example for Free

Health Care Marketing EssayThe United States spends much than $4.2 billion annually as a resource to market in the direction of health handle consumers. Advertisements consist of pharmaceuticals, alternative medicine, and in many cases, lawsuits as a result of alleged bad drugs. The two forms of selling are direct to consumer advertising (DTCA) of medicines to treat a disease or illness, and direct advertisements reaching a more diverse populace of health tutelage consumers requiring medication. Through the practice of print advertisements, television announcements, radio commercials, the far-reaching side effect of health care marketing is fast becoming an epidemic. My Opinion on legitimate Health Care Marketing TechniquesWhile my opinion on health care is apparent, I also realize the ever-changing atmosphere and understand that with transfer come additional responsibilities. From first-hand accounts and voice-to-voice with family in the health care arena, I am doubtful t hat all possible improvements have been implemented. It is my desire to see a more established forefront to the real problems in health care. We have great potential in this country to improve the processes and services available to health care consumers.How I feel Current Marketing Techniques Are Affecting Consumers?Marketing techniques, in my opinion, often overstep the boundary of ethical behavior more specially regarding the use of pharmaceutical marketing techniques. I often wonder just about the validity of claims made on behalf of pharmaceutical companies, providing vast amounts of info to an unrecognized audience.A recent content analysis of 38 television commercials concluded that the emotional appeal overshadowed factual information about the drug only 26% of commercials provided information about the causes of or risk factors for disease, and 19% suggested lifestyle changes as adjunctive treatments Pharmaceutical constancy Profile 2007. This information has aided in f orming an opinion about how techniques are often over-extended to reach a more diverse population, often with disregard to how this information is perceived by the audience.ConclusionI am grateful for the opportunity to participate in this course. My hopes are to expand my understanding of the processes of health care marketing, learning all the facets of techniques, capabilities, and social responsibilities.ReferencesPharmaceutical Research and Manufacturers of America. Pharmaceutical Industry Profile 2007. Washington, DC PhRMA, 2007.

Wednesday, June 5, 2019

Supply and Demand of the Rubber market

Supply and Demand of the Rubber trade2.0 IntroductionNatural hawkshaw crossroad such as raw synthetic prophylactic and hevea wood products are kinds of world bulk industrial raw material they are scare, deficient and strategic resource important for national vindication and industrial construction. Due to the shortfall of prophylactic tag on and climate changes in the rubber-producing countries, add together resource of natural rubber has been decreasing annually and it makes global market suffering from significantly high price of the rubber (Hanim Adnan 2011).The insufficient supply of the natural rubber has bought various issues to the rubber market and it has brought contri howeverion to the economics of Malaysia. at that placefore, pertinent economic theories will be used to discuss in the natural rubber issues. This report will examine in the concepts of have, supply, shortages, market equilibrium, and elasticity. Besides, well label diagrams will be including in th e later paragraph to explain the whole concepts.3.0 Analysis3.1 DemandThe effects of shift in demand on rubber market count on 1.1D0D1S0P1P0Q0 Q1 standard scatheDemand can be defined as An economic measure, which shows an unlimited desire, as well as the superpower to buy for a products or services (Demand 2011).According to the executive officer of glove manufacturer Careplus Group Bhd Lim Kwee Shyan, demand surged because of making medical rubber gloves payable to growing hygiene awareness following the H1N1 pandemic. Therefore, it has become an essential product for the healthcare industry (Kian Seong 2010).Besides, there is a strong demand for tyres from China and India of the motorcar sector (Prices to Stay High on Ongoing Tight supply 2011). Hence, ceteris paribus, there is a high demand to the natural rubber especially when the step-up of population and the healthcare awareness has elevated.From Figure 1.1, it shows the effects of shift in demand on rubber market. Further more, the number of buyer is a non-price determinant, when the buyers summation the measuring stick of a product they want to buy at a given price it makes the market demand curve shift to rightward from D0 to D1 in the Figure 1.1. Therefore, crude equilibrium price and the quantity demand increase from P0 to P1 and Q0 to Q1, respectively.3.2 SupplySupply can be described as The total amount of a product or service available for the customer to purchase at a given price (Supply 2011).Figure 1.2D0S0S1The effects of shift in supply on Rubber marketQuantityPriceP1P0Q1 Q0The extreme and changeable weather of Malaysia and the issues of global warming will affect latex flow and reduce the supply of the rubber. For example the higher temperature in the morning and unpredictable natural disaster which are detrimental to the rubber trees (Admin 2011).Malaysia now was facing the shortage of rubber clones imputable to the changeable weather and over-tapping the rubber trees which raise the problem of supply shortage (Jack 2011).Expectation of producers is a non-price factor so it shifts the supply curve to the leftward from S0 to S1. However, the quantity of rubber supplied decrease from Q0 to Q1 because of weather problem and unable to produce at given output, resulting in increase price of rubber from P0 to P1 shown in Figure 1.2.3.3 ShortageFigure 2.1ShortageQ Q1 QQuantityThe Effects of shift in demand on rubber marketPricePnP0ED1S0D0Figure 2.1ShortageQ Q1 QQuantityPricePnP0ED1S0D0The Effects of shift in demand on rubber marketThere is excess demand and the supply for the natural rubber is limited, it brings the resulting of shortage which has consequently led to price increase in the Malaysia since 2008 (World rubber supply tight, but price outlook bullish 2010).From Figure 2.1, at P0, as demand shifts from D0 to D1, it shows the demand has increase and the equilibrium price has move from P0 to Pn shows that the quantity of supply also increase. However, in the Fi gure 2.2, the supply shifts from S0 to S1, which means decrease in supply and the equilibrium price has increase from P0 to Pn and decrease in quantity demanded.As a conclusion, through Figure 2.1 and Figure 2.2, both of them showed a shortage which is the shaded theatrical role where the quantity demanded (Q1) exceeds quantity supplied (Q0). Besides, an upward pressure fall on the price of rubber due to the shortage and when the price is at Pn resulting a new equilibrium, dit E and the quantity demanded is at Q1, as shown in Figure 2.1 and Figure 2.2.3.4 Market Equilibrium Changes in EquilibriumEquilibrium described as in a market occurs when the price balances the plans of buyers and sellers (Hubbard, 2009).Bernama stated that the prices of natural rubber will continuously rise in this year but the output of the natural rubber in February has drop if compare to January whereas the demand increase in world markets (February Rubber Output down 15.8 Per Cent 2011).Figure 3.1S1SDD1 P1P0QQuantityPriceSupply Demand for Rubber marketIn the change in equilibrium, there is increase in Demand and decrease in supply. There Therefore, the demand curve shift rightward from D to D1 and supply curve shift leftward from S to S1, as shown in Figure 3.1. The new equilibrium price increase and move from P0 to P1. But there is no change in Quantity. The equilibrium price rise up but quantity is indeterminate.3.5 SubsidySmallholders can5.0 reference work ListsAdnan, Hanim. 2011. Right time for renewed interest in rubber sector. The Star.http//biz.thestar.com.my/news/story.asp?file=/2011/4/5/business/8412507sec=busi ness (Accessed April 1, 2011).Demand. 2011. Investor Glossary. http//www.investorglossary.com/demand.htm (Accessed April 1)..Kian Seong, Lee. 2011.Careplus gains 4 sen premium on ACE Market debut. The Star. http//biz.thestar.com.my/news/story.asp?sec=businessfile=/2010/12/7/business/756724 2 (Accessed April 2, 2011).Supply. 2011. Business Dictionary.com. http//www .businessdictionary.com/definition/supply.html (Accessed April 2, 2011).Admin. 2011. Global warming threat to natural rubber. Srilankan rubber Industry. http//slrubberindustry.com/2011/01/19/global-warming-threat-to-natural-rubber/ (Accessed April 2, 2011)Jack Wong. 2011. Rubber board unveils planting scheme. The Star. http//biz.thestar.com.my/news/story.asp?file=/2011/3/29/business/8364614sec=business (Accessed April 2).World rubber supply tight, but price outlook bullish. 2010. Bloomberg. http//www.engineeringnews.co.za/article/global-outlook-for-rubber-supplies-are-bullish-2010- 02-12 (Accessed April 3, 2011).February Rubber Output Down 15.8 Per Cent. 2011. Bernama. http//www.bernama.com/bernama/v5/newsbusiness.php?id=578466 (Accessed April 12, 2011)

Tuesday, June 4, 2019

Off-loading for the Prevention of Diabetic Foot Ulceration

Off-loading for the Pr planetion of Diabetic Foot UlcerationTHE ROLE OF OFF-LOADING IN THE PREVENTION OF DIABETIC FOOT ULCERATIONINTRODUCTION OF DIABETIC FOOT ULCERIn the modern techno-world diabetic metrical unit ulcer is the most putting green reason of lower extremity amputation which makes it highly essential that ulceration in the rear end of a patient with Diabetes mellitus must be cutn guardianship of straightway or else it impart egest to a more serious condition and the end result will be amputation of the leg. As stated in The lancet arch an early diagnosis is imminent as this condition has high chances of recurring even after the ulcer is plowed but medical noise bottom of the inning prevent amputation. Health caution research has been neglecting the importance of planning and taking adequate prophylactic measures to prevent the onset of diabetic stand ulceration and discussion were being given based on clinical diagnosis and results but more importance was t o be given to scientific facts and extensive studies were to be through to assess the root cause of the relative incidence of diabetic foot and well timed(p) measures were to be taken (1).Patients with diabetes have higher chances of getting hospitalized with foot problems and this can still be taken care of by a careful analysis by the family physician during the patients r out(a)ine visits. Simple office tests such as the nylon fibril test (2) can be performed in the office so that those patients in the assay category can be identified and prophylactic measures can be taken to prevent the ulcer from forming. This is a simple test wherein the feet are examined and the pressure is applied on certain pressure points in the feet and if the patient is non able to sense the pressure applied then he is considered at risk for developing an ulcer in the region and the doctor advises him to take spear carrier care to prevent the ulcer from forming.In spite of seeking medical help diab etic foot ulcers often develop to more chronic conditions and want of timely intervention to prevent this condition may lead to amputation of the lower extremities and at times may even be fatal. In a popular case-by-case, when harmful pressure is applied on the feet making it difficult for the person to handle, then the brain sets off a pain alarm (1). But, in the matter of diabetic patients, due to excessive nerve damage the sensation of pain is lost and an ulcer forms and this will be noticed only after it is besides late to redeem. But, with the advent of technology and medical science off-loading helps in preventing further damages and one has to choose the right kind of off-loading modality that suits ones purpose.Risk Factors for patients suffering from diabetic foot (2)1.Nerve cell damage hence lack of pain sensation2.Deformed foot and callus formation3.Decreased sweating, dry, fissured skin4.Obesity5.Limited Joint mobility6.Poor glucose control leading to unhealed woun ds7.Foot wear issues that can lead to skin breakdown and ulcers8.History of foot ulcersPREVALENCEStudies conducted in the double-u of Ireland to assess the prevalence of diabetic foot complications show that almost 4.7% (Institute of Public wellness in Ireland, 2006) of the population is suffering from the debilitating disease called diabetes and out of which an increasing majority of patients are suffering from developing foot ulcers of which some of them have already abidene lower extremity amputation. Pilot studies conducted among a sizeable number of diabetes population in the west of Ireland shows that they have vascular insufficiency and have neural dysfunction in the feet. These data are to be treated with concern as these prevalent conditions are associated with increased risk of ulceration which left unattended will lead to more irreversible complications (Nather et al, 2008) (3).INCIDENCEThe need of podiatric inputs in the field of diabetic foot oeuvre is unavoidable and for this pilot studies, researches, data cumulative study must be done to prevent incidence of diabetic foot complications in the Irish population. Pilot studies conducted on diabetic foot complications in the west of Ireland undo that pedal neural dysfunction was detected in up to 30% of the screened population and vascular impairment in 17% of those screened (3). With timely intervention and prophylactic measures the part of diabetic foot ulcers can be controlled and with just an initial investment of podiatric clinics across the republic of Ireland the scotch impact of growing incidence of diabetic foot ulcers and associated disorders that can lead to downfall of the healthcare system can be reduced and stabilized.COSTIn developed countries, health care resources account that diabetes- cerebrate complications are the most costly and studies conducted at St. James Hospital, Dublin reveal that the annual hospital expenditure on the treatment of diabetic foot ulceration amoun ted to 74,000 pounds (Smith et al., 2004). In an Irish healthcare setting, the cost of managing diabetic foot ulceration was studied and on screening of thirty patients who were admitted for diabetic foot complications it was revealed that out of the thirty, amputations were performed in eight of the patients and one died with a non- meliorate ulcer. The net hospital expenditure was 704,000 and an average of 23,489.63 per admission (4).IMPACTAccording to Dr. Canavan, almost 50% of the people with diabetes who undergo a lower limb amputation are of working age and that HSE was not channeling the financial and human resources in the health system effectively to tackle diabetes. The lineal in-patient costs amount to 239 million (4) and this is estimated only for the hospital care and not for the cost of dressings or antibiotics. Taking all of these factors into account it has become of national economic importance to devise a national strategy to manage diabetes so that the healthcare resources need not be spent on preventable complications. kinda the financial resources must be channeled for setting up more diabetic perplexity clinics with podiatric clinical settings and recruitment of diabetic specialists.The theoretical role of off-loading in the case of diabetes mellitusSince a diabetic patient has lost the sensation of pain it becomes difficult for the patient to identify a minor bruise that may develop into an ulcer. coerce simplification or off-loading is essential for a patient who has just been treated for diabetic foot. Wound care is essential in case of diabetes effective management and off-loading or reducing the pressure plays a significant role in managing the ameliorate process. There are various off-loading modalities such as the total-contact curlicues (TCC), removable cast walkers (RCW) and half shoes and studies have been conducted to compare the effectiveness to heal neuropathic foot ulcerations in diabetic individuals (5). Although les s commonly used than RCW and half shoes the results reveal that TCC is better than the other two off-loading modalities and TCC heals comparatively higher number of wounds in a shorter duration of time (6). Customized therapeutic footwear is manufactured to suit the individual needs taking into account the deformity and the pressure points. Published studies reveal that TCC are a better option compared to other modalities but clinical adroitness is essential for its application (7). But another factor that is to be taken into consideration is that removable cast walkers enable daily wound inspection and timely care for the wound which is difficult in the former modality. However, one can conclude that wounds on the posterior heal cannot be treated with TCC although it has significant healing percentage. The best feature of RCW is paradoxically its disadvantage (8). Since this is removable it has the disadvantage of forced adherence which is taken care of by TCC which makes it a bet ter alternative to treat neuropathic foot.Evidence of Impact of off-loadingHigh risk diabetic feet is often prone to deformities and offloading of these feet is essential to prevent its recurrence. Diabetic foot ulcer has high chances of recurring even after healing if proper care is not taken to prevent its occurrence. The diabetic feet has certain high risk locations and research on clinical trials by Arts et al. show that highest success rates were seen at previous ulceration areas and Charcot feet whereas forefoot deformities showed the lowest success rates. Studies comparing the effectiveness of RCW and instant TCC showed comparable results in the healing of foot ulcers. In this study it was concluded that a significantly higher proportion of people using the TCC healed faster when compared to those using the RCC. Pressure reduction using the advancement in medical technology will be the corner stones of treatment so that lower extremity amputations can be avoided (9). intellig enceStudies reveal that Ireland has the minimum number of podiatrists and hence effective management of diabetes foot is not possible. Effective measures must be taken to ensure that more answer medical professionals specializing in this field must be recruited and diabetic foot clinics are set up where clinical tests like nylon filament tests are conducted for patients during their go check-up in order to ensure that they are not at risk and counseling must be provided to create their awareness about foot ulcers and the risk factors associated with lower extremity amputation. According to the present scenario the current national and international guidelines (NICE, 2004 IDF, 2009 SIGN, 2010) advise that diabetic patients must receive a comprehensive annual foot examination and this must be done on a regular basis.ConclusionA team approach by the family physician and relatives is essential to creating a general awareness for the patient to improve foot hygiene and nail care. In ad dition to this the patient must understand that routine checkups are necessary and the doctor must also perform frequent foot examinations during the routine visits. Early detection is the key to controlling the incidence of this condition and ensuring the medical practitioners take adequate measures to do a routine examination during every hospital visit. Effective management of diabetic foot ulceration has a positive economic impact on the Irish health care budget and the health care system must take preventive measures to provide prophylactic care to diabetic patients and effective measures to educate the patients about pedal hygiene and its importance. Taking into account the importance of podiatry input in effective management of diabetic foot the manpower deficit in the country of Ireland must be accounted for and fulltime podiatrists (90-100) must be assigned to the country to manage diabetes related complications.REFERENCESWilliam JJ and Prof Keith JH. Diabetic foot Ulcers. The Lancet 2003 361 154551.David GA and Lawrence A.L. Diabetic Foot Ulcers Prevention, Diagnosis and Classification. Am Fam Physician 1998 57(6) 1325-32.Sarah et al. Prevalence of Diabetic foot complication in the West of Ireland A pilot study. The Diabetic Foot diary 2010 13(2)82-91.Smith D, Cullen MJ and Nolan JJ. The cost of managing diabetic foot ulceration in an Irish hospital. Irish Journal of Medical Science 2004 173(2) 89-92.Adler AI, Boyko EJ, Ahroni JH and Smith DJ. Lower-extremity amputation in diabetes. E independent effects of peripheral vascular disease, sensory neuropathy and foot ulcers. http//care.diabetesjournals.org/content/24/6/1019.fullGerit M, David A, Susie S. Standard, Appropriate, and move on Care and Medical Legal Considerations Part one Diabetic Foot Ulcerations. Wounds 200315(4)Armstrong DG, Lavery LA. Evidence-based options for offloading diabetic wounds. Clin Podiatr Med Surg 1998 1595-104Stephanie W and David A. Managing the diabetic foot treatment, wound care and off-loading techniques. Diabetes section 2005 50 (Special Issue)29-32.Armstrong DG, Lavery LA, Wu S, Boulton AJ. Evaluation of removable and irremovable cast walkers in the healing of diabetic foot wounds a randomized controlled trial. Diabetes Care 2005 28 551-4.

Monday, June 3, 2019

Composition Of Amlodipine Besylate Tablets Biology Essay

Composition Of Amlodipine Besylate Tablets Biology Essay(28) Karalis et al in 2008 dish aerialussed the issues in the conference involved physiological factors affecting medicate absorption, the role of pre-systemic effect on bioavailability (BA), the impact of variability in bioequivalence (BE) studies, and a final closing panel session on unresolved issues in BA/BE regulations. Several important aspects of dose absorption were highlighted. It was presented how the complexity of gastroin shewinal (GI) physiology and the site dep rarityent absorption can impact on drug BA. Similarly, the effects of food and formulation were also studied. The second session foc delectationd on integrating the complexities of GI into modeling the inter- individual(a) variability of absorption and the prediction of first-pass metabolism from in-vitro data. The extremity to measure metabolites, the value of Biopharmaceutical Classification System (BCS), and the more than recently proposed Biopharm aceutical Drug Disposition Classification System (BDDCS) were assessed as well. This session closed with presentations of pharmacokinetic softw atomic number 18 delegates. In the second day of the conference, the problem of high intra-subject variability in BE studies was analyze. Study design considerations, the use of multiple-dose studies and the role of statistics in BE were also highlighted. Finally, the certain thinking of regulatory authorities (EMEA and US-FDA) was presented. The conference closed with a last session on unresolved issues in the regulatory level.data-basedTablets are the approximately popular dosage forms of Pharmaceutical product. A typical tablet formulation consists of the Active Pharmaceutical ingredient(s), fillersdisintigrant, lubricant and some other in participating ingredients (e.g. binder, glidant and colors) a formulation scientist must conduct a thorough both to optimize a formulation so that it meets all specification and to ensure safety a nd efficacy. The specification for pharmaceutical tablets usually include appearance, tip, uniformity of contant, diameter, Thickness, friability, decomposition, looseness, Hardness, Assay, Organolaptic character other product specific requirements. These specifications are established to ensure that the tablets will have sufficient mechanical distinctiveness to live on packaging, shipping and handling and are physically and chemically stable to deliver the accurate amount of drug at the desired dis dissolving agent rate when consumed by the patient. Any changes in these characteristics may significantly affect the safety and efficacy of the product.FORMULATION DEVELOPMENT OF AMLODIPINE BESYLATE BY DIRECT COMPRESSION ruleDirect condensate is a preferred manufacturing process for pharmaceutical tablets, gibe to survey conducted by Shangraw and Demarest. In this study Amlodipine besylate was directly mean by utilize three diametrical formulation i.e. with several(predic ate) diluent,bibder,filler,disintigrant and lubricant.In this study we were not only study the biowaivers effect of different marketed brands and formulation of Amlodipine Besylate merely also manufactured and developed three different formulation by reducind the cost and increased quality perspects.MATERIAL AND METHODCHEMICALS.COMPOSITION OF AMLODIPINE BESYLATE TABLETS.FORMULATION NO.1S.NO.Material NameQuanty perTablet (mg)Percentage composition (%) measuring for 100 tablets (gm)1Amlodipine Besylate550.52Avecil 10247474.73Starch Pregelitinized47.7547.754.7754Magnesium stearate0.250.250.025Target concretion weight is 100mg containing 5 mg activeFORMULATION NO.2S.NO.Material NameQuanty perTablet (mg)Percentage composition (%)Quantity for 100 tablets (gm)1Amlodipine Besylate550.52Avecil ci47474.73Avecil 10247474.74Magnesium stearate110.1Target compression weight is 100mg containing 5 mg activeFORMULATION NO.3S.NO.Material NameQuanty perTablet (mg)Percentage composition (%)Quantity for 100 tablets (gm)1Amlodipine Besylate550.52Avecil 10249494.93Dicalcium Phosphate Anhydrous44444.44Sodium Starch Glycolate440.45Magnesium stearate110.1Target compression weight is 100mg containing 5 mg activeEQUIPMENTSRotary press ( ZP19)Electronic match (Sartorious TE 214S)Mixer ( polyethylene bag )Sieve 20METHODThree new formulation of Amlodipine Besylate were developed using three directly compressible agents i.e. microcrystalline cellulose (Avecil 101 and 102), starch pregelatinized and Dibasic Calcium Phosphate in nightclub to check the multi purpose excipients. First active and all excipients were weighed accurately using Sartorious TE 214S, The weighed poppycocks were screened through 20 mesh size sieve and then fuse of gunpowders was performed by geometric dilution method in polythene bag. First active was mixed with diluents by tumbling action and then angiotensin-converting enzyme by one other ingredients of formulation were mixed together. All the ingredients we re thoroughly mixed to ensure uniform distribution of all the ingredients throughout the formulation.Flow chart of manufacturing process advisement of active and excipientsSieving y 20 mesh sizeMixing of active and diluentAddition of other ingredientsAddition of lubricant and mixingTabletingPHYSICAL test OF TABLETAmlodipine Besylate tablets were evaluated for their physical and chemical properties by perfor instantg different pharmacopoeial test, i.e by official and unofficial tests including tablets weight variation, hardness, friability, disintegration, dissolution, Thickness, diameter and confine uniformity and results were statistically analyzed and compared with marketed brands of Amlodipine Besylate named as test formulation 1, test formulation 2, test formulation 3TABLET THICKNESS AND DIAMETERThe dimensional specifications of tablets are important for m whatever an(prenominal) reasons. The measurement of the ponderousness and the diameter of a tablet usually accomplish ed by the use of micrometer (Vernier) calipers. The value is initially employed as in process control during production. harmony OF THICKNESSEQUIPMENTSVernier caliperMETHODTablet thickness is determined with a caliper or thickness gauge, which measures the thickness in millimeters. In this study, twenty tablets were taken and their thicknesses were determined using vernier caliper. Results were statistically analyzed using three sigma control chart.LIMITSA plus or minus 5% standard deviation may be allowed, depending on the size of the tablet.Out of twenty tablets only two tablets will be allowed to exceed the limit.UNIFORMITY OF DIAMETER OF TABLETSEQUIPMENTVernier caliperMETHODTwenty tablets were taken and their diameters were determined using vernier caliper. . Results were statistically analyzed using three sigma control chart.LIMITSA deviation of 5% from the stated diameter is allowed except that for diameters exceeding 12.5mm the deviation allowed is 3%.Out of 20 tablets only 2 tablets will be allowed to exceed the limit. crumbliness block outA certain weight of tablets ,are subjected to a well defined level of agitation in a fixed geometry,closed container for a specific duration.They are then again reweighted.The measure of abrasion resistance or FRIABILITYis usually expressed as a percentage loss in weight.EQUIPMENTElectronic parallelism (Sartorious TE 214S)Friabilator (Erweka Germany)METHODPreweight samples of 20tablets were taken and subjected to the combined effect of shock abrasion by utilizing the plastic chamber which revolved at 25rpm for 4minutes, droped the tablet at a distance of 6 inches with each revolution. Then the tablets were removed, dedusted and reweighed.LIMITSValues of friability of 0.8 to 1.0% are frequently quoted as the upper level of acceptability for pharmaceutical product. Generally the test is run once. If the results are doubtful for if weight loss is greater than 1% replicates the test twice and determines the mean of t he three tests. A maximum weight of 1% of the weight of the tablets to be tested is considered to be acceptable for most products.HARDNESS TESTThis test is intended to determined at a lower place defined conditions,the resistance to inhibition of tablets,measured by the drived needed to disturp them by crushing setup.Probably the most widely used technique is testing of crushing strength presisly defined as that compressional force which,when applied diametrically to a tablet,just fractures it.EQUIPMENTHardness tester (Pharma test)METHODTwenty tablets of every sample of brands and test formulation were taken and their hardness was determined using Pharma test hardness tester. In this type of tester load is applied at a constant rate by an electric motor. Results were statistically analyzed using three sigma control chart.LIMITSHardness will be measured in kg.Out of twenty tablets only two tablets are allowed to exceed the limit.DISINTIGRATION TEST FOR TABLETSDisintegration Test determines whether tablets or capsules crumble within the prescribed time when placed in the liquid medium in the experimental condition prescribed. For compressed uncoated tablets the testing fluid is usually water at 37 C, but in some cases monographs direct that simulated gastric fluid TS be used.This test is provided to determine whether tablets or capsules disintegrate within the prescribed time when placed in a liquid medium under the experimental conditions presented below.For the purposes of this test, disintegration does not imply complete dissolution of the unit or even of its active constituent. Complete disintegration is defined as thatState in which any residue of the unit, except fragments of insoluble coating or capsule shell, remaining on the screen of the test apparatus or adhering to the lower surface of the discs, if used, is a soft mass having no palpably firm core.Use apparatus A for tablets and capsules that are not greater than 18 mm long. For larger tablets or capsules use apparatus B.APPARATUSThe apparatus consists of a field goalful-rack group, a 1 liter, low-form beaker, 149 11 mm in height and having an in spite of appearance diameter of 106 9 mm for the immersion fluid, a thermostatic arrangement for heating the fluid between 35 C and 39 C, and a device for raising and lowering the wicket in the immersion fluid at a constant frequency rate between 29 and 32 cycles per minute, through a distance of 55 2 mm. The people of the fluid in the vessel is such that at the highest point of the upward stroke the wire mesh clay at to the lowest degree 15 mm below the surface of the fluid, and descends to not less than 25 mm from the bottom of the vessel on the downward stroke. At no time should the top of the basket-rack assembly become submerged. The time required for the upward stroke is equal to the time required for the downward stroke, and the change in stroke counsel is a smooth transition, rather than an abrupt reversal of motion. The basket-rack assembly moves vertically along its axis. There is no appreciable horizontal motion or sweat of the axis from the vertical.BASKET-RACK ASSEMBLYThe basket-rack assembly consists of 6 open-ended transparent tubes, each 77.5 2.5 mm long and having an inside diameter of 21.85 1.15 mm and a wall 1.9 0.9 mm thick the tubes are held in a vertical position by 2 plates, each 90 2 mm in diameter and 6.75 1.75 mm in thickness, with 6 holes, each 24 2 mm in diameter, equidistant from the centre of the plate and equally spaced from one another. Attached to the under surface of the lower plate is a woven stainless steel wire cloth, which has a plain square weave with 2.0 0.2 mm mesh apertures and with a wire diameter of 0.615 0.045 mm. The parts of the apparatus are assembled and rigidly held by bureau of 3 bolts passing through the 2 plates. A suitable means is provided to suspend the basket-rack assembly from the raising and lowering device using a point on it s axis. The design of the basket-rack assembly may be varied slenderly provided the specifications for the glass tubes and the screen mesh size are maintained. The basket-rack assembly conforms to the dimensions.DISCS The use of discs is permitted only where specify or allowed. Each tube is provided with a cylindrical disc 9.5 0.15 mm thick and 20.7 0.15 mm in diameter. The disc is made of a suitable, transparent plastic material having a specific gravity of 1.18-1.20. 5 correspond 2 0.1 mm holes extend between the ends of the cylinder. One of the holes is centered on the cylindrical axis. The other holes are centered 6 0.2 mm from the axis on imaginary lines perpendicular to the axis and parallel to each other. 4 identical trapezoid boneal-shaped planes are cut into the wall of the cylinder, nearly perpendicular to the ends of the cylinder. The trapezoidal shape is harmonious its parallel sides coincide with the ends of the cylinder and are parallel to an imaginary line c onnecting the centres of 2 adjacent holes 6 mm from the cylindrical axis. The parallel side of the trapezoid on the bottom of the cylinder has a length of 1.6 0.1 mm and its bottom edges lie at a depth of 1.6 0.1 mm from the cylinders circumference. The parallel side of the trapezoid on the top of the cylinder has a length of 9.4 0.2 mm and its centre lies at a depth of 2.6 0.1 mm from the cylinders circumference. All surfaces of the disc are smooth.If the use of discs is specified, add a disc to each tube and operate the apparatus as directed under Procedure. The discs conform to the dimensions. The use of automatic detection employing circumscribed discs is permitted where the use of discs is specified or allowed. Such discs must comply with the requirements of density and dimension.PROCEDUREPlace 1 dosage unit in each of the 6 tubes of the basket and, if prescribed, add a disc. Operate the apparatus using the specified medium, maintained at 37 2 C, as the immersion fluid. A t the end of the specified time, lift the basket from the fluid and observe the dosage units all of the dosage units have disintegrated completely. If 1 or 2 dosage units fail to disintegrate, repeat the test on 12 additional dosage units. The requirements of the test are met if not less than 16 of the 18 dosage units tested have disintegrated.EQUIPMENTDisintegrating weapon (Pharma Test)METHODTest 6 tablets or capsules either by using 2 basket-rack assemblies in parallel or by repeating the procedure. In each of the 3 tubes, place 1 tablet or capsule and, if prescribed, add a disc suspend the assembly in the beaker containing the specified liquid. Operate the apparatus for the prescribed period, withdraw the assembly and examine the state of the tablets or capsules. To pass the test, all 6 of the tablets or capsules must have disintegrated.LIMITSAll tablets must disintegrate completely, if one or two tablets fails to disintegrate, the test is to be repeated using 12 tablets. Out of the 18 tablets then tested,16 must have disintegrated within the abandoned period of time .The condition of the test are varied somewhat for coated tablets,buccal tablets and sublingual tablets. Disintegration time are included in the individual tablet monograph. For most uncoated tablets the period is less than 15 minutes although the time for some uncoated tablets varied greatly from this.WEIGHT VARIATION or so pharmacopoeias include a simple weight test on a specified number of tablet(N) which are weight individually and the arithmetic mean weight calculated.Limitations on the number of test tablets that may lie outside certain limits are than specified.However,in the USP the results of the assay are used to convert these weights into active ingredients content.EQUIPMENTSElectronic respite (Sartorious TE 214S)METHODTwenty tablets of every samples were taken randomly and eight individually, and then average weight was determined.LIMITSAccording to USP not more than two of the t ablets must not differ by more than the percentage listed below, no tablet differs by more than double that percentage. Tablets that are coated are exempt from these requirements but most conform to the test for content uniformity if it is applicable. The USP has provided tolerance for the average weight of uncoated compressed tablets. These are applicable when the tablets contain 50mg or more of the drug substances or when the matter comprises 50% or more, by weight, of the dosage form.Average Weight%age Difference130mg or less10130mg to 324 mg7.5More than 324mg5ASSAYAMLODIPINE BESYLATEREAGENTS0.1N Sodium Hydroxide in MethanolDimethyl formamide (DMF)STANDARD SOLUTION50mcg/ml of Amlodipine Besylate in DMF.SAMPLESOLUTIONExtract appropriate quantity of pulverise sample with DMF to get concentration of 50mcg/ml.PROEDURETo 2ml each of sample and standard solution, add 0.2ml of Sodium hydroxide solution and dilute to 10ml with DMF and measure the absorption of orange chromatogen at 450n m against reagent blank. Calculate the table of contents of amlodipine by comparison.(237)AMLODIPINE BESYLATEThe tablets comply with the requirment stated under tablet and with the following requirment.CONTENT OF AMLODIPINE BESYLATEC20H25ClN2O5,C6H6O3S 97.0% to 102.0% (Anhydrous substance)CHEMICALSSodium hydroxide pelletsMethanolN-N Dimethyl FormamideEQUIPMENT AND GLASS WARESElectronic Balance (Sartorious TE 214S)UV-VIS spectrophotometer (Double beam Shimadzu 1650PC )Volumetric Flask (100ml,Pyrex England)Volumetric Flask (10ml,Pyrex England)Pipettes (10ml Pyrex England)Pipettes (2ml Pyrex England)Conical Flasks (Pyrex England)Beaker (Pyrex England)Filter write up (Whatman 42)METHODWeigh and powder 20tablets of amlodipine Besylate 5mg (DC). Take quantity of the powder containing 5mg of amlodipine Besylate (average weight) in a 100ml volumetric flask and add N-N Dimethyl Formamide into it and mix thoroughly with the help of magnetic stirrer and then make up the volume up to 100ml.The n take 2ml from first dilution into a 10ml volumetric flask, add 0.2l of 0.1N Sodium hydroxide solution in 10ml volumetric flask then make up volume with N-N Dimethyl Formamide.Then take the absorbance at 450nm on spectrophotometer and calculate the content of amlodipine Besylate.CALCULATION(AMLODIPINE BESYLATE mgtablet)% ASSAY = Abs of sp X__ 100Abs of STDUNIFORMITY OF CONTENTThe test for uniformity of content of single-dose preparations is based on the assay of the individual contents of active substance(s) of a number of single-dose units to determine whether the individual contents are within limits set with reference to the average content of the sample. Tablets containing highly potent medicaments present in milligram or microgram does may be subject to a large inter tablet variation. This may be due to failure to achieve a homogenous mix of active ingredient and exciient during manufacture.The test is not required for multivitamin and trace-element preparations and in other j ustified and authorized circumstances.Method Using a suitable analytical method determines the individual contents of active substance(s) of 10 dosage units taken at random.Apply the criteria of test A, test B or test C as specified in the monograph for the dosage form in question.Test ATablets, powders for parenteral use, ophthalmic inserts, suspensions for shootingTest BCapsules, powders other than for parenteral use, granules, suppositories, pessaries Test CTransdermal patchesTest ATablets, powders for parenteral use, ophthalmic inserts, suspensions for injection The preparation complies with the test if each individual content is between 85 per cent and 115 per cent of the average content. The preparation fails to comply with the test if more than one individual content is outside these limits or if one individual content is outside the limits of 75 percent to 125 percent of the average content.If one individual content is outside the limits of 85 percent to 115 percent but wit hin the limits of 75 percent to 125 percent, determine the individual contents of another 20 dosage units taken at random. The preparation complies with the test if not more than one of the individual contents of the 30 units is outside 85 percent to 115 percent of the average content and none is outside the limits of 75 percent to 125 per cent of the average content.CONTENT UNIFORMITYC.U = Abs of essay X wt of std X 100 X 100Abs of STD X 100 X LC* LC =Label claimDISSOLUTIONThis test is provided to determine compliance with the dissolution requirements for solid dosage forms administered orally.Apparatus 1 (Basket apparatus) the assembly consists of the following a vessel, which may be covered, made of glass or other inert, transparent material a motor a drive shaft and a cylindrical basket (stirring element). The vessel is partially immersed in a suitable water-bath of any commodious size or heated by a suitable device such as a heating jacket. The water-bath or heating device per mits maintaining the temperature inside the vessel at 37 0.5 C during the test and keeping the dissolution medium in constant, smooth motion. No part of the assembly, including the environment in which the assembly is placed, contributes significant motion, agitation, or vibration beyond that due to the smoothly rotating stirring element. Apparatus that permits observation of the preparation and stirring element during the test is preferable. The vessel is cylindrical, with a hemispherical bottom and a capacity of 1 litre. Its height is 160-210 mm and its inside diameter is 98-106 mm. Its sides are flanged at the top. A fitted cover may be used to retard evaporation.2 The shaft is positioned so that its axis is not more than 2 mm at any point from the vertical axis of the vessel and rotates smoothly and without significant careen that could affect the results. A speed-regulating device is used that allows the shaft rotation speed to be selected and maintained at a specified rate, within 4 per cent.Shaft and basket components of the stirring element are fabricated of stainless steel, type 316 or equivalent, to the specifications shown in Figure 2.9.3.-1.A basket having a gold coating of about 2.5 m (0.0001 inch) thick may be used. The dosage unit is placed in a dry basket at the beginning of each test. The distance between the inside bottom of the vessel and the bottom of the basket is maintained at 25 2 mm during the test.Apparatus 2 (Paddle apparatus) Use the assembly from Apparatus 1, except that a paddle formed from a blade and a shaft is used as the stirring element. The shaft is positioned so that its axis is not more than 2 mm from the vertical axis of the vessel, at any point, and rotates smoothly without significant wobble that could affect the results. The vertical center line of the blade passes through the axis of the shaft so that the bottom of the blade is flush with the bottom of the shaft. The paddle conforms to the specifications shown in F igure 2.9.3.-2. The distance of 25 2 mm between the bottom of the blade and the inside bottom of the vessel is maintained during the test. The metallic or fitly inert, rigid blade and shaft comprise a single entity. A suitable two-part detachable design may be used provided the assembly remains firmly engaged during the test. The paddle blade and shaft may be coated with a suitable coating so as to make them inert. The dosage unit is allowed to sink to the bottom of the vessel before rotation of the blade is started. A small, loose piece of non-reactive material, such as not more than a few turns of wire helix, may be attached to dosage units that would otherwise float. An alternative halo device is shown in Figure 2.9.3.-3. Other validated sinker devices may be used.DISSOLUTION MEDIUM1.2 pH caramel DISSOLUTION MEDIAREAGENTS USEDHtdrochloric Acid (Merck grade)Distilled and deionized waterPREPARATION0.1N HCl was used as 1.2pH buffer media.4.5 pH BUFFER DISSOLUTION MEDIAREAGENTS US EDPotassium Dihydrogen Phosphate (Merck,Germany)Distilled and deionized waterPREPARATION6.8gm of Potassium Dihydrogen Phosphate in1000ml DI water and adjust pH with Phosphoric acid.6.8 pH BUFFER DISSOLUTION MEDIAREAGENTS USED0.2M Potassium Dihydrogen hosphate0.1M Sodium hydroxideDistilled and deionized waterPREPARATION0.2M KH2PO4 13.61gm of Potassium Dihydrogen hosphate in 500ml DI water.0.1MNaOH 4gm in 500ml DI water.6.8pH Buffer 250ml of 0.2M KH2PO4 and 112ml of 0.1MNaOH to make 1000ml with DI water.CALCULATION% age drug release = Abs of sp X100Abs of STDSAMPLING SCHEDULESample were drawn at 5min thenAfter 10minAfter 15minAfter 20minAfter 30minAfter 45minAfter 60minAfter 120minEXPERIMENTAL CONDITIONSUsual experimental conditions are e.g.Apparatus paddle/basketVolume of dissolution medium 900 mlTemperature of the dissolution medium 37 C1CAgitation paddle apparatus usually 50 rpm, basket apparatus usually 100 rpmSampling schedule e.g.5, 10, 15, 20, 30, 45, 60, and 120 minBuffer pH 1.2 (0.1 N HCl or SGF without enzymes), pH 4.5, and pH 6.8 (or SIF withoutenzymes) (pH should be ensured throughout the experiment Ph.Eur. buffers recommended)CHEMICALSBuffer 1.2 pH (0.1N HCl)Buffer 4.5 pHBuffer 6.8 pHEQUIPMENT AND GLASS WARESDissolution paddle apparatusDistillation plantElectronic Balance (Sartorious TE 214S)UV-VIS spectrophotometer (Double beam Shimadzu 1650PC )Volumetric Flask (100ml,Pyrex England)Pipettes (10ml Pyrex England)Pipettes graduated(2ml Pyrex England)Conical Flasks (Pyrex England)Beaker (Pyrex England)Filter paper (Whatman 42)PREPARATION OF STANDERDAccurately weight the standard and poured it into 100ml volumetric flask.The volume was made with the respective buffer and mixed,the stock solution was obtained.Then pippet out 1.1ml from the stock solution into another volumetric flask again made the volume with the respective buffer solution .Mixed it properly by shaking that was the first dilution and the required strength of standard was achieved to a nalyse.PREPARATION OF SAMPLEPlaced the tablets of each brand into the vessel of paddle dissolutionhaving 900ml of resoective dissolution media.Switch on the apparatus and collect the sample according to the respective sampling interval that is 5min, 10min, 15min, 20min, 30min, 45min, 60min, and 120min.Every time the withdrawn media was replaced by the freh media.

Sunday, June 2, 2019

Essay --

The Battle of Britain began July 10th 1940 when Germany launched the first bombing raid against Great Britain. Hitler, the chancellor of Germany and dictator of Nazi Germany, declared, The German Air Force is to overcome the British Air Force with all means at its disposal, and as soon as possible. Hitlers goal was for Germany to achieve superiority in the skies by gaining the possesion of the air space owned by Great Britain. It was after successfully occupying France that Germany turned its sights on Britain and gathered their forces in preparation for an air brush up. On July 10th the onslaught commenced. Germanys Air Forces struck at British shipping convoys in the channel off the south coast of Britain. Occasionally they dive-bombed the cargo ships, but the first sort of the attack was mostly alone a way to get things moving. It was relatively simple, Hitler wanted to give his pilots an opportunity to train and also wanted to observe Britains defenses. British pilots and res ources took a severe hit defending the convoys, and eventually they were forced to re-route the convoys in order to avoid the Channel. Attacks on the convoys lasted up until the 12th of August. During this time raids were also make on the ports of Dover and Plymouth, two important Royal Navy shore establishments.Three days after the Battles beginning the Luftwaffe, the aerial warfare ramification of the German Air Force during World War Two, began to lay mines around Britain. This tactic would continue on into early September.During the first phase of Germanys assault The Royal Air Force was dangerously outnumbered, however they also had many favorable assets. One of their greatest advantages being that they possessed a radar that was considered to be th... ...y the end of phase two more raids had been ordered on Royal Air Force airfields, and there seemed to be no end in sight, and it just got worse in phase three. Phase three marked the beginning of Germany targeting not just mi litary, but also civilian establishments. In the night loaded down(p) bombing raids commenced over london. These raids continued regularly into late september, and to a lesser severity proceeded to happen for several years.Because of a setback on August twenty-fourth due to poor weather conditions and a dwindling number of bombers Germany was forced to change tactics. They set their sights back southeast and worked on taking out race Command. The German Air Force managed to be successful in heavily damaging six out of seven primary bases in the southeast secern of of England. In some cases the bases had suffered enough damage to seriously limit their efficiency.

Saturday, June 1, 2019

Impacts of National Healthcare Reform Essay example -- health care, A

Health circumspection in the United States has become one of the biggest, most debated issues in todays society and people post concerns over quality, accessibility, choice, cost and dozens of other factors. Politicians on both sides of the aisle have tried to use healthcare issues to their advantage, Democrats talking about the right that solely Americans should have to quality healthcare while Republicans hammer on the tremendous cost and its impact on the governments deficit and on business. With the transportation of the Patient Protection and Affordable Care Act (PPACA) on March 23, 2010, the debate has intensified. The Centers for Medicare and Medicaid Services, the US governmental agency that administers Medicare and Medicaid, found that the decree would do short to stem the rise in healthcare expenditures which are expected to increase to more than twenty percent of gross domestic product in the neighboring decade. However, at the same time, President Obama stated t hat The Health Care Reform Bill we passed last year will slow these rising costs, which is part of the tenability that nonpartisan economists have said that repealing the health care law would add a quarter of a trillion dollars to our deficit. My Administration projects significant savings from the health care reform. This paper will not attempt to tackle the issue of whether the overall impact of the bill will be more positive or negative to the US economy. The goal of this paper is to outline why addressing healthcare is so important economically and then to explore any(prenominal) specific aspects of the PPACA legislation, much(prenominal) as the mandate for coverage, the elimination of pre-existing conditions and coverage rescissions, allowing subject coverage until age 26, and the additio... ...s provisions does not guarantee any degree of understanding of the overall impact this legislation will have. However it is possible to look at various aspects of the legislat ion and forecast the implications of those changes. Certain protections that the bill provides, like expansion of dependent coverage, elimination of pre-existing conditions and prohibition of rescissions of coverage, will positively impact some people but will generally cause higher health care costs. Other aspects of the bill, like the medical loss ratio requirements and the coverage mandates, will impact businesses differentially. I believe in its totality, smaller employers will get some benefit out of the legislation while larger employers are likely harmed. However, it will be years after this law is enacted, and likely modified, that the true impacts of the legislation are known.